{"news_desk": "OpEd", "print_page": "2", "subsection_name": "Sunday Review", "section_name": "Opinion", "byline": {"original": "By ELISABETH ROSENTHAL", "person": [{"firstname": "Elisabeth", "rank": 1, "lastname": "ROSENTHAL", "organization": "", "role": "reported"}]}, "abstract": "Op-Ed article by Elisabeth Rosenthal points to controversy surrounding Mylan's increase of prices on EpiPen auto-injectors as example of how federal government has no tools with which to regulate pharmaceutical industry's pricing practices; result is often prohibitive consumer costs for life-saving drugs.", "type_of_material": "Op-Ed", "word_count": "1217", "keywords": [{"rank": "1", "value": "Medical Devices", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Epinephrine (Drug)", "is_major": "Y", "name": "subject"}, {"rank": "3", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "5", "value": "Trademarks and Trade Names", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Mylan Inc", "is_major": "Y", "name": "organizations"}, {"rank": "7", "value": "Bresch, Heather", "is_major": "N", "name": "persons"}], "lead_paragraph": "Government has no real tools to curb extortionate prices.", "pub_date": "2016-09-04T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "Government has no real tools to curb extortionate prices....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-thumbWide.jpg"}, {"height": 440, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "440", "xlarge": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/09/04/opinion/sunday/04rosenthal/04rosenthal-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/09/04/opinion/sunday/the-lesson-of-epipens-why-drug-prices-spike-again-and-again.html", "slideshow_credits": null, "blog": [], "_id": "57c9b2b395d0e021d79841ab", "headline": {"main": "The Lesson of EpiPens: Why Drug Prices Spike, Again and Again", "content_kicker": "Opinion", "print_headline": "Old Drug, Pricey New Package", "kicker": "Opinion"}}